What Is UroLift and How Does It Work
UroLift is a minimally invasive medical device designed to treat lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate. The procedure involves placing small implants in the prostate gland to compress excess tissue and widen the urethra—the tube that carries urine out of the body. Unlike surgical removal of prostate tissue, UroLift uses mechanical compression to improve urine flow without cutting or destroying tissue.
Free Guide to Check Cashing Time Limits →
The UroLift system consists of tiny implants made of nitinol (a shape-memory metal alloy) and polyester. Each implant is about the size of a grain of rice. During the procedure, a urologist uses a specialized delivery catheter to place these implants strategically within the prostate. The implants work by lifting and holding the compressed tissue away from the urethra, creating more space for urine to pass through. Most men receive between 2 and 6 implants, depending on the size and shape of their prostate.
According to clinical studies, approximately 78% of men experienced significant improvement in urinary flow rates within two weeks of receiving UroLift implants. The procedure itself typically takes 20 to 30 minutes and is performed in an outpatient setting, meaning patients go home the same day. Many men report noticeable improvement in symptoms within one to two weeks, with continued improvement over three months as swelling decreases.
The procedure has been FDA-approved since 2013 and has been used to treat more than 200,000 men worldwide. Because it preserves prostate tissue and does not require general anesthesia, UroLift offers an alternative to more invasive surgical options like TURP (transurethral resection of the prostate) or open prostatectomy. The implants are designed to be permanent, though they can be removed or repositioned if needed.
Practical Takeaway: Understanding that UroLift is a mechanical implant system—not medication or tissue removal—helps you recognize why this approach differs from other prostate treatments. The procedure is designed for outpatient use with minimal downtime, making it worth exploring if you experience BPH symptoms.
Medicare Coverage and Cost Information
Medicare Part B covers UroLift procedures when they are deemed medically necessary and performed by an in-network urologist at an approved facility. The coverage decision depends on several factors, including proper medical documentation of BPH symptoms and unsuccessful conservative treatment. Medicare reimburses for both the procedure and the device itself, though costs to the beneficiary vary based on individual circumstances.
Get Your Free Safelite Appointment Scheduling Guide →
The total cost of a UroLift procedure typically ranges from $5,000 to $15,000 when paid out-of-pocket, depending on geographic location, the facility, and the number of implants required. However, for Medicare beneficiaries, out-of-pocket costs are generally much lower. You would typically pay for the Part B deductible (currently $226 in 2024) and then 20% of the approved Medicare amount for the facility and physician services. If you have supplemental insurance (Medigap) or a Medicare Advantage plan, your actual costs may be substantially less.
The approval process for Medicare coverage usually begins with your urologist's office submitting documentation of your condition and treatment history. Medicare requires evidence that conservative treatments—such as watchful waiting or medication like alpha-blockers or 5-alpha reductase inhibitors—have been attempted or deemed inappropriate before approving UroLift. This documentation protects your interests by ensuring the procedure is truly necessary for your situation.
It's important to note that private insurance coverage varies widely. Some commercial insurance plans cover UroLift, while others may require prior authorization or deny coverage entirely. The procedure's relatively recent approval means some insurers may still be developing their coverage policies. Your specific coverage depends on your individual plan's terms and conditions, which you can review in your plan documents or by contacting your insurance company directly.
Practical Takeaway: Contact your Medicare carrier or review your plan documents to understand your specific out-of-pocket costs. Ask your urologist's billing department whether they can check your coverage before scheduling, as this prevents surprises and helps you plan financially.
Common Symptoms of BPH That UroLift May Address
Benign prostatic hyperplasia affects millions of men, particularly those over age 50. The prostate gland naturally enlarges with age in many men, and when it becomes large enough, it can compress the urethra and interfere with normal urination. The symptoms of BPH are progressive, meaning they often worsen gradually over months or years. Recognizing these symptoms helps you understand whether UroLift information might be relevant to your situation.
Get Your Free Photo Sharing by Email Guide →
Common BPH symptoms include a weak or interrupted urine stream, difficulty starting urination, frequent urination during the day (eight or more times), nighttime urination (nocturia) that disrupts sleep, urgency to urinate, and incomplete bladder emptying. Many men experience a combination of these symptoms rather than just one. For example, a man might wake four to six times per night to urinate and also notice that his stream is noticeably weaker than it was years ago. These symptoms can significantly affect quality of life, sleep, and daily activities.
The severity of BPH symptoms does not always correlate with prostate size. Some men with very enlarged prostates have minimal symptoms, while others with smaller enlargement experience bothersome problems. This is why medical evaluation is essential—your urologist can assess both your prostate size using ultrasound or other imaging and your symptom severity using standardized questionnaires like the International Prostate Symptom Score (IPSS).
It's crucial to understand that BPH is not cancer, and having BPH does not increase your cancer risk. However, untreated BPH can occasionally lead to complications such as urinary tract infections, bladder stones, or acute urinary retention (sudden inability to urinate). This is why many men choose to pursue treatment—not because BPH is dangerous, but because symptoms interfere with their daily life and sleep quality. A free informational guide about UroLift would explain how this procedure addresses these specific symptoms.
Practical Takeaway: Keep a symptom diary for one to two weeks, noting how many times you urinate daily and nightly, and any difficulty with your stream. Bring this to your doctor's appointment—it provides concrete information that helps your urologist recommend appropriate next steps.
Conservative Treatment Options Before Considering UroLift
Most medical guidelines recommend that men try conservative approaches first before considering surgical or device-based treatments for BPH. These approaches range from simple lifestyle modifications to medications that can significantly reduce symptoms for many men. Understanding these options is important because Medicare requires documentation that conservative treatments have been attempted before approving UroLift in most cases.
Learn About Device Registration and Key Factors →
Watchful waiting is often the first approach, particularly for men with mild symptoms that do not substantially interfere with daily life. This strategy involves monitoring symptoms over time without immediate treatment, while avoiding substances and behaviors that worsen BPH. Men are advised to limit fluid intake in the evening, reduce caffeine and alcohol consumption, avoid decongestants and antihistamines (which can worsen urinary retention), and practice double-voiding (urinating twice in succession to empty the bladder more completely). Research shows that many men's symptoms stabilize or improve somewhat with these lifestyle changes alone.
Medications represent the next level of conservative treatment. Alpha-blockers such as tamsulosin (Flomax) and doxazosin (Cardura) relax the muscles in the prostate and bladder neck, improving urine flow. These medications may improve symptoms in approximately 60% to 70% of men who take them. Five-alpha reductase inhibitors like finasteride (Proscar) and dutasteride (Avodart) reduce prostate size by blocking the conversion of testosterone to DHT (dihydrotestosterone), which drives prostate growth. These medications work best for men with larger prostates and may take three to six months to show benefit. Some men take combination therapy using both drug classes.
Beta-3 agonists such as mirabegron (Myrbetriq) represent a newer medication option that relaxes the bladder muscle, helping it empty more completely. The choice of medication depends on individual symptoms, other medical conditions, and how well the medication works for each person. Many men experience significant